These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17361979)

  • 21. A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function.
    Govoni M; Lim HD; El-Atmioui D; Menge WM; Timmerman H; Bakker RA; Leurs R; De Esch IJ
    J Med Chem; 2006 Apr; 49(8):2549-57. PubMed ID: 16610798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
    Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
    Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series.
    Rivara M; Zuliani V; Cocconcelli G; Morini G; Comini M; Rivara S; Mor M; Bordi F; Barocelli E; Ballabeni V; Bertoni S; Plazzi PV
    Bioorg Med Chem; 2006 Mar; 14(5):1413-24. PubMed ID: 16263297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.
    Black LA; Nersesian DL; Sharma P; Ku YY; Bennani YL; Marsh KC; Miller TR; Esbenshade TA; Hancock AA; Cowart M
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1443-6. PubMed ID: 17169555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aplysamine-1 and related analogs as histamine H3 receptor antagonists.
    Swanson DM; Wilson SJ; Boggs JD; Xiao W; Apodaca R; Barbier AJ; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2006 Feb; 16(4):897-900. PubMed ID: 16300945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.
    Petroianu G; Arafat K; Sasse BC; Stark H
    Pharmazie; 2006 Mar; 61(3):179-82. PubMed ID: 16599255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning and characterization of the monkey histamine H3 receptor isoforms.
    Strakhova MI; Fox GB; Carr TL; Witte DG; Vortherms TA; Manelli AM; Miller TR; Yao BB; Brioni JD; Esbenshade TA
    Eur J Pharmacol; 2008 Dec; 601(1-3):8-15. PubMed ID: 18977214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists.
    Roche O; Nettekoven M; Vifian W; Sarmiento RM
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4377-9. PubMed ID: 18606542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Ishikawa S; Sekino E; Sasaki T; Fujimura T; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Fukami T; Sato N
    J Med Chem; 2008 Aug; 51(15):4780-9. PubMed ID: 18598020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.
    Labeeuw O; Levoin N; Poupardin-Olivier O; Calmels T; Ligneau X; Berrebi-Bertrand I; Robert P; Lecomte JM; Schwartz JC; Capet M
    Bioorg Med Chem Lett; 2013 May; 23(9):2548-54. PubMed ID: 23535326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
    Łazewska D; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 May; 14(10):3522-9. PubMed ID: 16466921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists.
    Heinrich T; Böttcher H; Prücher H; Gottschlich R; Ackermann KA; van Amsterdam C
    ChemMedChem; 2006 Feb; 1(2):245-55. PubMed ID: 16892357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists.
    Jitsuoka M; Tsukahara D; Ito S; Tanaka T; Takenaga N; Tokita S; Sato N
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5101-6. PubMed ID: 18768318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
    Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
    Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keynote review: histamine H3 receptor antagonists reach out for the clinic.
    Celanire S; Wijtmans M; Talaga P; Leurs R; de Esch IJ
    Drug Discov Today; 2005 Dec; 10(23-24):1613-27. PubMed ID: 16376822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel (E)-alpha-[(1H-indol-3-yl)methylene]benzeneacetic acids as endothelin receptor ligands.
    Pittalà V; Romeo G; Materia L; Salerno L; Siracusa MA; Modica M; Mereghetti I; Cagnotto A; Russo F
    Farmaco; 2005 Sep; 60(9):731-8. PubMed ID: 16043172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new family of H3 receptor antagonists based on the natural product Conessine.
    Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Sengupta D; Duffield JJ; Semple G; Webb RR; Sage C; Ren A; Pereira G; Knudsen J; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Whelan K; Grottick AJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1490-4. PubMed ID: 18194865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.
    Volk B; Barkóczy J; Hegedus E; Udvari S; Gacsályi I; Mezei T; Pallagi K; Kompagne H; Lévay G; Egyed A; Hársing LG; Spedding M; Simig G
    J Med Chem; 2008 Apr; 51(8):2522-32. PubMed ID: 18361484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.